LAG3 and cancer: Our previous study showed that both adenosine derivatives, N6, N6-dimethyladenosine, CD, adenosine-inhibited DPP4/CD26 expression in cancer cells, and adenosine further revealed that it significantly suppresses the expression of the lymphocyte activating factor 3 (Lag3) in mice with AD injection.